Generic Arcoxia is used for treating acute and chronic pain, osteoarthritis and rheumatoid arthritis. It is also used for management of ankylosing spondylitis and relief of chronic musculoskeletal pain. It is also used for treating gout.
Generic Didronel is used for treating adults with Paget disease, and preventing and treating abnormal bone growth following hip replacement surgery or spinal cord injury.
Generic Indocin is used for treating moderate to severe rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout or certain types of bursitis and tendonitis.
Generic Indocin Extended-Release is used for treating moderate to severe rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout or certain types of bursitis and tendonitis.
Generic Ponstel is in a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). It is used to treat pain or inflammation caused by arthritis. It is also used to treat menstrual pain.
Drug for osteoporosis linked to cancer - Dr. Cutler
Sydney Morning HeraldDrug for osteoporosis linked to cancerDr.
Health Canada Approves Denosumab for Postmenopausal Women With Osteoporosis - DG News
Health Canada Approves Denosumab for Postmenopausal Women With OsteoporosisDG NewsNEW YORK -- September 8, 2010 -- Health Canada has approved denosumab (Prolia) for the treatment of postmenopausal women with osteoporosis at high risk for .
Preventing and treating osteoporosis: lifestyle changes can make a difference - AnnArbor.com
Preventing and treating osteoporosis: lifestyle changes can make a differenceAnnArbor.
Stroke and osteoporosis screening coming to Miramar Beach - Walton Sun
Stroke and osteoporosis screening coming to Miramar BeachWalton SunA bone density screening to assess osteoporosis risk is also offered and is appropriate for both men and women.
Unigene to Present at the Rodman & Renshaw 12th Annual Healthcare Conference - MarketWatch (press release)
Unigene to Present at the Rodman & Renshaw 12th Annual Healthcare ConferenceMarketWatch (press release)Due to the size of the worldwide osteoporosis market, Unigene is targeting its initial efforts on developing calcitonin and PTH-based therapies.
